Results 321 to 330 of about 351,718 (359)
Some of the next articles are maybe not open access.
Cytogenetics and bone marrow transplantation
Cancer Genetics and Cytogenetics, 1986The authors report hematologic and cytogenetic data on 19 patients treated with allogeneic bone marrow transplantation (BMT) for severe hematologic disorders: 8 patients with chronic myelogenous leukemia, 6 with acute leukemia, 3 with severe aplastic anemia, 1 with refractory anemia, and 1 with beta-thalassemia major.
PALKA, Giandomenico +9 more
openaire +3 more sources
Bone marrow transplantation in India
The Indian Journal of Pediatrics, 1987Beginning in early 1983, bone marrow transplantation (BMT) facilities in India have undergone slow but steady growth. With about 50% disease-free survival in acute myeloid leukaemia and aplastic anaemia and 90% survival in thalassemia major, the results are encouraging. However, the outcome in chronic myeloid leukemia so far has been poor.
Suresh H. Advani, Tapan K. Saikia
openaire +4 more sources
The pathology of bone marrow transplantation
Histopathology, 1993The pathological complications of bone marrow transplantation are complex and may affect any organ in the body. The causes are often multifactorial and include the effects of chemotherapy, the conditioning regimen, drugs used in the post‐transplant period such as immunosuppressants and antibiotics, graft‐versus‐host disease (GvHD) and the effects of ...
John P. Sloane, J. Norton
openaire +2 more sources
Allogeneic bone marrow transplantation
Seminars in Oncology Nursing, 1994From highly investigational to standardized therapy, allogeneic BMT has established its role in the treatment of selected diseases. Continued refinements in bone marrow transplantation will increase the number of potential candidates, reduce associated risks, and improve disease-free survival rates.
Theresa Franco, D. Allen Gould
openaire +3 more sources
Transplantation proceedings, 1971
Improvements in the results of bone marrow transplantation for the treatment of SCID may be expected by employing purified stem-cell concentrates for patients who do not have a compatible sibling available. Refinements in the purification technique and its monitoring are required, however.
openaire +2 more sources
Improvements in the results of bone marrow transplantation for the treatment of SCID may be expected by employing purified stem-cell concentrates for patients who do not have a compatible sibling available. Refinements in the purification technique and its monitoring are required, however.
openaire +2 more sources